Carbodissection of the internal thoracic artery  by Edwin Lee, Myles
The operative time it takes to recon-
struct the pericardium is not significant,
and the diaphragmatic reconstruction is not
facilitated in our experience by leaving the
pericardium in.
Finally, we agree that personal experi-
ence with chylothorax should guide each
surgeon as to whether prophylactic thoracic
duct ligation should be used routinely.
Lambros Zellos, MD
David J. Sugarbaker, MD
Department of Thoracic Surgery
Brigham and Women’s Hospital
Boston, MA 02115-6195
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Technique for microsphere injection
To the Editor:
We read with great interest the article by
Hedayati and associates1 recently pub-
lished in the Journal. The authors sug-
gested that axillary artery cannulation for
cardiopulmonary bypass is cerebroprotec-
tive from aortic atheroemboli by using ca-
nine models. We respectfully would like to
note some procedural inconsistencies that
might have lead to bias in the authors’
conclusions.
The authors assessed the distribution of
microspheres simulating aortic atheroem-
boli shed by patients during cardiopulmo-
nary bypass. However, the microsphere in-
jection method was inconsistent (eg, the
pump flow was not constant, and the rate of
microsphere injection was unclear), and the
reference blood withdrawal rate for calcu-
lating tissue blood flow was unclear. Be-
cause the distribution pattern of the micro-
spheres can be influenced easily by the
pump flow rate, microsphere injection rate,
shape of the aorta, and location of the in-
jection, more precise experimental proto-
cols might affect this study’s results.
One more point of concern in this study
is the size of the microspheres. Small mi-
crospheres (15 m in diameter) have been
used for measuring tissue blood flow,2 and
large microspheres (50 m in diameter)
have been used for creating microemboli3
by several investigators. Hedayati and
associates1 used microspheres 15 m in
diameter; however, they did not use the
microspheres to measure tissue blood flow
but rather as microemboli in this study.
Because atheroemboli are generally larger
than 15 m in diameter and because size
affects the degree of cerebral ischemia and
infarction,4 we believe that the larger mi-
crosphere should have been used to analyze
the risk of atheroemboli in the aorta during
cardiopulmonary bypass.
In light of these considerations, the au-
thors’ conclusion that “axillary artery can-
nulation for cardiopulmonary bypass is ce-
rebroprotective” cannot be fully supported
on the basis of the data presented. More
studies with larger microspheres or flow
characterization with both particle image
velocimetry and laser Doppler velocimetry
could provide more meaningful results and
insights on this subject to further under-
stand this clinically important topic.
Yoshio Ootaki, MD, PhD
Kiyotaka Fukamachi, MD, PhD
Department of Biomedical Engineering
Lerner Research Institute
The Cleveland Clinic Foundation
Cleveland, OH 44195
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Reply to the Editor:
Thank you for your interest in our publica-
tion entitled “Axillary artery cannulation
for cardiopulmonary bypass reduces cere-
bral microemboli.” We are confident that
our conclusion, that axillary cannulation
reduces cerebral microemboli, is supported
by our experimental evidence. We apolo-
gize for any lack of clarity with our exper-
imental design. We agree that the distribu-
tion pattern of the microspheres might be
influenced by the pump flow rate, micro-
sphere injection rate, shape of the aorta,
location of the injection, and location of the
cardiopulmonary bypass cannulation site.
Using each animal as its own control en-
abled us to provide constant conditions for
each variable, with the only difference be-
ing the cannulation site.
Our microsphere injection method
was consistent for each animal. The only
variable was the cannulation site for car-
diopulmonary bypass. The pump flow
rate was constant during the 2 cannula-
tion techniques within each animal, al-
though the pump rate did vary from 1.9 to
3.4 L · min1 · m2 among animals to
maintain constant pressure among ani-
mals. Five million microspheres (2.5 
106 microspheres/mL) were injected over
1 minute.
Larger microspheres have been used to
induce infarction or ischemia and might
have been preferred if that was our inten-
tion. We were exclusively interested in the
distribution of the spheres and found no
evidence that the distribution of 50-m
spheres would have, in our model, altered
our impressive results. Atheroemboli range
in size, with the most numerous being the
smallest.1 We used 15-m spheres, as has
been done before in similar investigations.2
We agree with your suggestion that fur-
ther characterization of the flow pattern
through particle-imaging techniques will
provide additional evidence as to the supe-
rior ability of axillary cannulation to pro-
vide cerebroprotection, and we plan to do
so in the future to further corroborate the
vastly reduced stroke rate we have ob-
served when axillary perfusion was used in
our patients with high-risk aortas.
Steve J. Schomisch, BS
Alan H. Markowitz, MD
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Carbodissection of the internal
thoracic artery
To the Editor:
I write with reference to the article by
Özkan and associates titled “A Carbon Di-
oxide Insufflation Technique for Prepara-
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tion of the Internal Thoracic Artery,”
which appeared in the April 2003 issue of
the Journal.1 This report resurrects a tech-
nique I described years ago in an article
titled “Carbodissection of the Internal Tho-
racic Artery Pedicle,” which appeared in
The Annals of Thoracic Surgery.2 1 was
pleased that Dr Özkan used this technique
with the same success I have observed
since 1988 but was disappointed that, per-
haps through an oversight, Dr Özkan chose
not to reference my work. The important
issue is not who performed the procedure
first but that Dr Özkan’s observation vali-
dates the efficacy of the technique.
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Reply to the Editor:
We thank Dr Lee for responding to our
article and for his comments.
Carbon dioxide insufflation, as a
method of preparation of the internal tho-
racic artery, is not novel. Dr Lee first in-
troduced this technique in 1988.1 Later,
Bognolo and associates2 used the same
technique in 1995. We also have used the
carbon dioxide insufflation technique since
2002 without citing Drs Lee and Bognolo.3
After this omission was noticed, we re-
ferred to Drs Lee and Bognolo in our next
article,4 titled “Effect of Carbon Dioxide
Insufflation on Free Internal Thoracic Ar-
tery Flows: Is it a Vasodilator?” which was
published in the Journal. We congratulate
Dr Lee for introducing this techique to
heart surgery.
Mehmet Özkan, MD
Private Camlica Omur Hospital
Department of Cardiovascular Surgery
Uskudar-Istanbul, Turkey
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We read with great interest the study by
Toumpoulis and colleagues,1 “Superiority
of Early Relative to Late Ischemic Precon-
ditioning in Spinal Cord Protection After
Descending Thoracic Aortic Occlusion”
published in the November 2004 issue of
the Journal. In their experimental model,
they revealed the superiority of early isch-
emic preconditioning (IP) in reducing spi-
nal cord injury caused by thoracic aortic
occlusion. IP is a new concept against spi-
nal cord ischemic injury. Although previ-
ous reports have demonstrated its benefi-
cial effects, there are still controversial
issues including the fundamental mecha-
nisms by which it provides protection and
the duration of reperfusion between 2 isch-
emic insults.
Recent experiments revealed a delayed
protective effect of IP, termed the “second
window of protection,” which appears
more than 24 hours after the initial isch-
emic insult. A subgroup of protein family,
called “stress proteins,” which are crucial
for the maintenance of cell integrity under
unfavorable conditions, are accepted as an
important cause of the “second window”
provided by IP. These stress proteins, in
particular, heat shock proteins (HSPs), are
able to alter the resistance of the tissues
to subsequent ischemic and nonischemic
insults.2,3
We have also examined this known
strategy, but our experience differs from
that of Toumpoulis and colleagues. We
used a rat model of spinal cord ischemia
and revealed that hyperthermic IP (HIP)
before transient aortic occlusion resulted
in improved neurologic and histopatho-
logic outcomes. In the IP group, we used
an early IP model with a reperfusion in-
terval of 30 minutes between 2 ischemic
insults. In the HIP group, rats were
heated to 41°C and maintained at this
temperature for 15 minutes. Twenty-four
hours later, the described early IP model
was also applied to this group of rats. The
spinal cord was extracted, and the lumbo-
sacral region was examined under light
microscopy to assess necrosis and under
electron microscopy to determine HSP-
ubiquitin positivity.
The neurologic evaluation of rats per-
formed on the first day did not reveal a
statistically significant difference between
the IP and HIP groups. However, on the
second day, we noticed a delayed neuro-
logic deterioration in the early IP group.
The neurologic scores of the HIP group
were significantly higher than those of the
IP group at the end of 48 hours (P  .05).
Histologic evaluation correlated well with
the neurologic outcome with lesser cellular
damage in the HIP group. Ubiquitin posi-
tivity was present only in hyperthermia-
pretreated animals.
On the basis of our experience, we
believe that a model with a short reper-
fusion interval does not provide the de-
layed anti-ischemic effect of IP, termed
the “second window,” which is possibly
related to the expression HSPs. Our re-
sults suggest that HSP-ubiquitin induc-
tion by heat stress may be responsible for
the delayed spinal cord protection seen in
this model. Whole-body hyperthermia
may have important clinical implications,
and further studies will delineate the fun-
damental mechanisms of hyperthermia-
induced neuroprotection.
Murat Basaran, MD
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